221 related articles for article (PubMed ID: 26292580)
21. Probing the binding of indolactam-V to protein kinase C through site-directed mutagenesis and computational docking simulations.
Wang S; Liu M; Lewin NE; Lorenzo PS; Bhattacharrya D; Qiao L; Kozikowski AP; Blumberg PM
J Med Chem; 1999 Sep; 42(18):3436-46. PubMed ID: 10479277
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of bryostatins and phorbol esters on arachidonic acid metabolite release and epidermal growth factor binding in C3H 10T1/2 cells.
Dell'Aquila ML; Herald CL; Kamano Y; Pettit GR; Blumberg PM
Cancer Res; 1988 Jul; 48(13):3702-8. PubMed ID: 3132318
[TBL] [Abstract][Full Text] [Related]
23. PKC activators (phorbol ester or bryostatin) stimulate outgrowth of NGF-dependent neurites in a subline of PC12 cells.
Burry RW
J Neurosci Res; 1998 Jul; 53(2):214-22. PubMed ID: 9671978
[TBL] [Abstract][Full Text] [Related]
24. Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60.
Kraft AS; Smith JB; Berkow RL
Proc Natl Acad Sci U S A; 1986 Mar; 83(5):1334-8. PubMed ID: 3456591
[TBL] [Abstract][Full Text] [Related]
25. Insertion Depth Modulates Protein Kinase C-δ-C1b Domain Interactions with Membrane Cholesterol as Revealed by MD Simulations.
Judge PT; Overall SA; Barnes AB
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902029
[TBL] [Abstract][Full Text] [Related]
26. Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C.
Wender PA; Cribbs CM; Koehler KF; Sharkey NA; Herald CL; Kamano Y; Pettit GR; Blumberg PM
Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7197-201. PubMed ID: 3174627
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase Calpha contains two activator binding sites that bind phorbol esters and diacylglycerols with opposite affinities.
Slater SJ; Ho C; Kelly MB; Larkin JD; Taddeo FJ; Yeager MD; Stubbs CD
J Biol Chem; 1996 Mar; 271(9):4627-31. PubMed ID: 8617724
[TBL] [Abstract][Full Text] [Related]
28. Residues in the second cysteine-rich region of protein kinase C delta relevant to phorbol ester binding as revealed by site-directed mutagenesis.
Kazanietz MG; Wang S; Milne GW; Lewin NE; Liu HL; Blumberg PM
J Biol Chem; 1995 Sep; 270(37):21852-9. PubMed ID: 7665608
[TBL] [Abstract][Full Text] [Related]
29. Protein kinase C ligands based on tetrahydrofuran templates containing a new set of phorbol ester pharmacophores.
Lee J; Kang JH; Lee SY; Han KC; Torres CM; Bhattacharyya DK; Blumberg PM; Marquez VE
J Med Chem; 1999 Oct; 42(20):4129-39. PubMed ID: 10514283
[TBL] [Abstract][Full Text] [Related]
30. Binding mode prediction of aplysiatoxin, a potent agonist of protein kinase C, through molecular simulation and structure-activity study on simplified analogs of the receptor-recognition domain.
Ashida Y; Yanagita RC; Takahashi C; Kawanami Y; Irie K
Bioorg Med Chem; 2016 Sep; 24(18):4218-4227. PubMed ID: 27436807
[TBL] [Abstract][Full Text] [Related]
31. Contrasting duration of inhibition of cell-cell communication in primary mouse epidermal cells by phorbol 12,13-dibutyrate and by bryostatin 1.
Pasti G; Rivedal E; Yuspa SH; Herald CL; Pettit GR; Blumberg PM
Cancer Res; 1988 Jan; 48(2):447-51. PubMed ID: 3422054
[TBL] [Abstract][Full Text] [Related]
32. Identification of potent, selective protein kinase C inhibitors based on a phorbol skeleton.
Yamatsugu K; Motoki R; Kanai M; Shibasaki M
Chem Asian J; 2006 Sep; 1(3):314-21. PubMed ID: 17441066
[TBL] [Abstract][Full Text] [Related]
33. Activation of conventional mammalian protein kinase C isoforms expressed in budding yeast modulates the cell doubling time--a potential in vivo screen for protein kinase C activators.
Shieh HL; Hansen H; Zhu J; Riedel H
Cancer Detect Prev; 1996; 20(6):576-89. PubMed ID: 8939343
[TBL] [Abstract][Full Text] [Related]
34. Demonstration of sub-nanomolar affinity of bryostatin 1 for the phorbol ester receptor in rat brain.
de Vries DJ; Herald CL; Pettit GR; Blumberg PM
Biochem Pharmacol; 1988 Nov; 37(21):4069-73. PubMed ID: 3190746
[TBL] [Abstract][Full Text] [Related]
35. Munc13 Is a Molecular Target of Bryostatin 1.
Blanco FA; Czikora A; Kedei N; You Y; Mitchell GA; Pany S; Ghosh A; Blumberg PM; Das J
Biochemistry; 2019 Jul; 58(27):3016-3030. PubMed ID: 31243993
[TBL] [Abstract][Full Text] [Related]
36. The synthetic bryostatin analog Merle 23 dissects distinct mechanisms of bryostatin activity in the LNCaP human prostate cancer cell line.
Kedei N; Telek A; Czap A; Lubart ES; Czifra G; Yang D; Chen J; Morrison T; Goldsmith PK; Lim L; Mannan P; Garfield SH; Kraft MB; Li W; Keck GE; Blumberg PM
Biochem Pharmacol; 2011 Jun; 81(11):1296-308. PubMed ID: 21458422
[TBL] [Abstract][Full Text] [Related]
37. Conformation of the C1 phorbol-ester-binding domain participates in the activating conformational change of protein kinase C.
Ho C; Slater SJ; Stagliano BA; Stubbs CD
Biochem J; 1999 Dec; 344 Pt 2(Pt 2):451-60. PubMed ID: 10567228
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective versus tumorigenic protein kinase C activators.
Nelson TJ; Alkon DL
Trends Biochem Sci; 2009 Mar; 34(3):136-45. PubMed ID: 19233655
[TBL] [Abstract][Full Text] [Related]
39. Structural Identification and Systematic Comparison of Phorbol Ester, Dioleoylglycerol, Alcohol and Sevoflurane Binding Sites in PKCδ C1A Domain.
Shi L
Protein J; 2018 Dec; 37(6):539-547. PubMed ID: 30251087
[TBL] [Abstract][Full Text] [Related]
40. Conformationally constrained analogues of diacylglycerol (DAG). 23. Hydrophobic ligand-protein interactions versus ligand-lipid interactions of DAG-lactones with protein kinase C (PK-C).
Tamamura H; Sigano DM; Lewin NE; Peach ML; Nicklaus MC; Blumberg PM; Marquez VE
J Med Chem; 2004 Sep; 47(20):4858-64. PubMed ID: 15369389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
